OBJECTIVE: The purpose of this study was to analyse retrospectively the intensity-modulated radiotherapy (IMRT) results in patients with head and neck cancer (HNC) treated between November 2003 and June 2007. METHODS: Patients with early and locoregionally advanced HNC were treated with inverse-planned step-and-shoot IMRT. The prescribed dose varied from 66 Gy to 70 Gy in those receiving IMRT as definitive treatment and from 60 Gy to 70 Gy in the post-operative setting. IMRT was given alone, after induction chemotherapy (ICT), with concomitant chemotherapy (CRT) or with both. Acute and late toxicities are reported; locoregional control (LRC), locoregional relapse-free survival (LRRFS) and overall survival (OS) were calculated from the start of radiation. RESULTS: IMRT was used in 78 patients (48 as definitive treatment, 30 post-operatively), of whom 20 also received ICT and 35 CRT. Three patients stopped IMRT early, one for toxicity (mucosa). Acute toxicity scoring revealed 5 cases (6%) of severe skin toxicity and 65 cases (83%) of severe mucosal toxicity. After a median follow-up of 18.7 months, late toxicities included xerostomia (44%), loss of taste (14%) and fibrosis of the neck (9%). 16 patients had died, of whom 10 due to tumour recurrence/progression and 2 due to treatment (but not IMRT related). The LRC, LRRFS and OS at 3 years are 66.1%, 48.5% and 60.3% in the definitive IMRT group and 85.4%, 82.5% and 85.9% in the post-operative setting, respectively. CONCLUSION: We consider IMRT for locoregional HNC feasible not only as a single modality but also after surgery, after induction chemotherapy and concurrently with chemotherapy.
OBJECTIVE: The purpose of this study was to analyse retrospectively the intensity-modulated radiotherapy (IMRT) results in patients with head and neck cancer (HNC) treated between November 2003 and June 2007. METHODS:Patients with early and locoregionally advanced HNC were treated with inverse-planned step-and-shoot IMRT. The prescribed dose varied from 66 Gy to 70 Gy in those receiving IMRT as definitive treatment and from 60 Gy to 70 Gy in the post-operative setting. IMRT was given alone, after induction chemotherapy (ICT), with concomitant chemotherapy (CRT) or with both. Acute and late toxicities are reported; locoregional control (LRC), locoregional relapse-free survival (LRRFS) and overall survival (OS) were calculated from the start of radiation. RESULTS: IMRT was used in 78 patients (48 as definitive treatment, 30 post-operatively), of whom 20 also received ICT and 35 CRT. Three patients stopped IMRT early, one for toxicity (mucosa). Acute toxicity scoring revealed 5 cases (6%) of severe skin toxicity and 65 cases (83%) of severe mucosal toxicity. After a median follow-up of 18.7 months, late toxicities included xerostomia (44%), loss of taste (14%) and fibrosis of the neck (9%). 16 patients had died, of whom 10 due to tumour recurrence/progression and 2 due to treatment (but not IMRT related). The LRC, LRRFS and OS at 3 years are 66.1%, 48.5% and 60.3% in the definitive IMRT group and 85.4%, 82.5% and 85.9% in the post-operative setting, respectively. CONCLUSION: We consider IMRT for locoregional HNC feasible not only as a single modality but also after surgery, after induction chemotherapy and concurrently with chemotherapy.
Authors: Gordon O Schoenfeld; Robert J Amdur; Christopher G Morris; Jonathan G Li; Russell W Hinerman; William M Mendenhall Journal: Int J Radiat Oncol Biol Phys Date: 2007-12-31 Impact factor: 7.038
Authors: Michelle L Klem; James G Mechalakos; Suzanne L Wolden; Michael J Zelefsky; Bhuvanesh Singh; Dennis Kraus; Ashok Shaha; Jatin Shah; David G Pfister; Nancy Y Lee Journal: Int J Radiat Oncol Biol Phys Date: 2007-11-05 Impact factor: 7.038
Authors: David I Rosenthal; Mark S Chambers; Clifton D Fuller; Neal C S Rebueno; John Garcia; Merrill S Kies; William H Morrison; K Kian Ang; Adam S Garden Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-01 Impact factor: 7.038
Authors: Pol M Specenier; Joost Weyler; Carl Van Laer; Danielle Van den Weyngaert; Jan Van den Brande; Manon T Huizing; Sevilay Altintas; Jan B Vermorken Journal: BMC Cancer Date: 2009-08-06 Impact factor: 4.430
Authors: Nancy Y Lee; William O'Meara; Kelvin Chan; Cesar Della-Bianca; James G Mechalakos; Joanne Zhung; Suzanne L Wolden; Ashwatha Narayana; Dennis Kraus; Jatin P Shah; David G Pfister Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-09 Impact factor: 7.038
Authors: Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad Journal: N Engl J Med Date: 2007-10-25 Impact factor: 91.245
Authors: Steven Seung; Joseph Bae; Matthew Solhjem; Stephen Bader; David Gannett; Eric K Hansen; Jeannie Louie; Kelly Underhill; Christine Cha Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-15 Impact factor: 7.038
Authors: Michael K M Kam; Sing-Fai Leung; Benny Zee; Ricky M C Chau; Joyce J S Suen; Frankie Mo; Maria Lai; Rosalie Ho; Kin-yin Cheung; Brian K H Yu; Samuel K W Chiu; Peter H K Choi; Peter M L Teo; Wing-hong Kwan; Anthony T C Chan Journal: J Clin Oncol Date: 2007-11-01 Impact factor: 44.544
Authors: Omar K Jilani; Prabhsimranjot Singh; A Gabriella Wernicke; David I Kutler; William Kuhel; Paul Christos; Dattatreyudu Nori; Albert Sabbas; Ks Clifford Chao; Bhupesh Parashar Journal: J Geriatr Oncol Date: 2012-10 Impact factor: 3.599
Authors: J O Brömme; M Schmücking; A Arnold; R Giger; D Rauch; D Leiser; L Plasswilm; A Geretschläger; P Ghadjar; D M Aebersold Journal: Strahlenther Onkol Date: 2013-07-04 Impact factor: 3.621
Authors: Dirk Van Gestel; Danielle Van den Weyngaert; Geert De Kerf; Bie De Ost; Olivier Vanderveken; Carl Van Laer; Pol Specenier; Yasmyne Geussens; Kristien Wouters; Els Meulemans; Kin Jip Cheung; Vincent Grégoire; Jan B Vermorken Journal: Oncologist Date: 2015-02-11
Authors: Sonja Stieb; Abdallah S R Mohamed; Tanaya S Deshpande; Jared Harp; Benjamin Greiner; Adam S Garden; Ryan P Goepfert; Richard Cardoso; Renata Ferrarotto; Jack Phan; Jay P Reddy; William H Morrison; David I Rosenthal; Steven J Frank; C David Fuller; G Brandon Gunn Journal: Clin Transl Radiat Oncol Date: 2020-03-24
Authors: Matthijs In 't Veld; Engelbert A J M Schulten; Frank K J Leusink Journal: Curr Opin Otolaryngol Head Neck Surg Date: 2021-04-01 Impact factor: 1.814